Yesterday, European stocks closed mixed. The Stoxx Europe 600 Index rebounded 0.20%, Germany's DAX 30 rose 0.41% and the U.K.'s FTSE 100 was up 0.43%, while France's CAC 40 declined 0.40%.
55% of STOXX 600 constituents traded higher yesterday.
29% of the shares trade above their 20D MA vs 26% Monday (below the 20D moving average).
51% of the shares trade above their 200D MA vs 51% Monday (below the 20D moving average).
The Euro Stoxx 50 Volatility index eased 1.77pt to 28.11, a new 52w high.
SECTORS vs STOXX 600
3mths relative high: Pers. & House. Goods
3mths relative low: Insurance, Banks
Europe Best 3 sectors
energy, automobiles & parts, technology
Europe worst 3 sectors
insurance, travel & leisure, basic resources
The 10yr Bund yield fell 5bps to -0.53% (below its 20D MA). The 2yr-10yr yield spread fell 1bp to -21bps (above its 20D MA).
GE 07:00: Oct GfK Consumer Confidence, exp.: -1.8
FR 08:15: Sep Markit Composite PMI Flash, exp.: 51.6
FR 08:15: Sep Markit Services PMI Flash, exp.: 51.5
FR 08:15: Sep Markit Manufacturing PMI Flash, exp.: 49.8
GE 08:30: Sep Markit Composite PMI Flash, exp.: 54.4
GE 08:30: Sep Markit Services PMI Flash, exp.: 52.5
GE 08:30: Sep Markit Manufacturing PMI Flash, exp.: 52.2
EC 09:00: ECB Non-Monetary Policy Meeting
EC 09:00: Sep Markit Composite PMI Flash, exp.: 51.9
EC 09:00: Sep Markit Services PMI Flash, exp.: 50.5
EC 09:00: Sep Markit Manufacturing PMI Flash, exp.: 51.7
UK 09:30: Sep Markit/CIPS Manufacturing PMI Flash, exp.: 55.2
UK 09:30: Sep Markit/CIPS UK Services PMI Flash, exp.: 58.8
UK 09:30: Sep Markit/CIPS Composite PMI Flash, exp.: 59.1
In Asian trading hours, the U.S. dollar strengthened further, as EUR/USD slid to 1.1680 and GBP/USD slipped to 1.2721. USD/JPY held gains at 105.12. NZD/USD fell further to 0.6620. This morning, the Reserve Bank of New Zealand kept its benchmark rate unchanged at 0.25% as expected. RBNZ said "further monetary stimulus may be needed", citing "a severe and prolonged economic downturn".
Spot gold was little changed at $1,901 an ounce.
#UK - IRELAND#
Halma, a manufacturer of hazard detection and life protection products, posted a trading update for the period from April 1 to date: "At the end of the first quarter we reported that revenue was 13% lower than last year on an organic constant currency basis. Since then, the Group's revenue trends have gradually improved, (...) Order intake was ahead of revenue albeit marginally down on the same period last year. (...) the Board continues to expect Adjusted profit before tax for FY2021 to be 5%-10% below FY2020 and more weighted to the second half than in previous years." Separately, the company announced that Paul Walker has indicated his intention to retire from his role as Chairman by July.
RELX, a provider of information-based analytics and decision tools, announced that Paul Walker, currently Chairman of Halma, will succeed Sir Anthony Habgood as Chairman.
Fresenius, a health care group, was upgraded to "overweight" from "equalweight" at Barclays.
Wacker Chemie, a chemical company, was upgraded to "buy" from "hold" at HSBC.
Veolia, a resource management company, is ready to engage in discussion with Engie regarding its proposal to acquire Engie's stake in Suez, according to news agency Agence France-Presse.
Sanofi and GlaxoSmithKline, the two pharmaceutical groups, said they have signed agreements with the Canadian government to supply up to 72 million doses of adjuvanted COVID-19 vaccine. Financial terms were not disclosed.
Orpea, a dependency care company, announced that 1H net income declined 36.3% on year to 73 million euros and EBITDA dropped 5.5% to 439 million euros on revenue of 1.90 billion euros, up 3.5%.
Proximus, a mobile telecommunications company, was downgraded to "neutral" from "buy" at Citigroup.
From a chartist point of view, the share is capped by a short term declining trend line since June. Furthermore, the 50 DMA is playing a resistance role, while a resistance at 49% maintains the RSI. Above the overlap at 17.5E look for 13.6E and 9.2E in extension.
Source: TradingView, GAIN Capital
Snam, an energy infrastructure company, was upgraded to "buy" from "sell" at Goldman Sachs.
Coloplast, a medical devices manufacturer, was downgraded to "underweight" from "equalweight" at Barclays.
From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.